乳腺保乳手术围术期多模式非阿片类镇痛路径消除阿片类药物使用
该研究于2017年1月实施保乳手术围术期多模式非阿片类镇痛路径,纳入226例患者,并与2016年历史数据比较。结果显示99%(223/226)患者出院后无需阿片类药物即可管理术后疼痛,阿片类药物使用率从2016年的40%降至路径实施后的1%(p<0.001)。
要点
- 多模式非阿片类镇痛路径可使99%保乳手术患者出院后无需阿片类药物。
- 路径包括术前对乙酰氨基酚、切口前布比卡因浸润、切除后布比卡因伤口沉积、术中酮咯酸、术后对乙酰氨基酚联合布洛芬及患者教育。
- 路径实施后阿片类药物使用率从40%降至1%,差异有统计学意义。
核心结论
- 实施多模式非阿片类镇痛路径后,99%的保乳手术患者出院后未使用阿片类药物。
研究设计与样本
- 单中心前瞻性路径实施研究,纳入226例保乳手术患者(平均年龄62±13岁),并与2016年历史机构数据比较。
主要发现
- 226例患者中50%(114/226)行单纯乳房切除术,50%(112/226)行乳房切除术加前哨淋巴结活检。
- 14例带处方患者中5例(36%)未取药,取药者中仅1例使用阿片类药物。
- 2例(1%)患者术后7天内因疼痛管理困难被开具阿片类药物。
- 最终99%(223/226)患者出院后未使用阿片类药物管理疼痛。
关键数值与推荐
- 阿片类药物使用率从2016年的40%降至路径实施后的1%,p<0.001。
临床怎么用
- 保乳手术可常规采用多模式非阿片类镇痛路径,包括术前对乙酰氨基酚、切口前布比卡因皮肤浸润、切除后布比卡因伤口沉积、术中酮咯酸、术后对乙酰氨基酚联合布洛芬及患者教育。
局限性
- 研究为单中心历史对照设计,未报告随机化或盲法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Opioid prescribing guidelines for partial mastectomy (PM) and PM with sentinel lymph node biopsy (PM-SLNB) recommend prescribing anywhere from 0 to 15 oxycodone pills for postoperative pain. We sought to eliminate opioids after breast-conserving surgery. STUDY DESIGN: In January 2017, we implemented a perioperative pathway in which patients received (1) preoperative acetaminophen, (2) pre-incisional bupivacaine skin infiltration, (3) post-excision bupivacaine wound deposition, (4) intraoperative ketorolac, (5) instructions to use both acetaminophen and ibuprofen for postoperative analgesia, and (6) counseling to set the expectation that opioids would not be required. We measured the percentage of patients who received, filled, and used opioid prescriptions. We compared this to historical institutional data from 2016. RESULTS: There were 226 patients (mean age: 62 ± 13 years) who underwent surgery: 50% (114 of 226) underwent PM alone and 50% (112 of 226) PM-SLNB. Twenty-four patients (11%) required opioids in the recovery unit, and 14 (6%) were discharged home with a prescription. Five of the 14 patients (36%) did not fill their prescription. Among the patients who did fill their prescription, only 1 patient used opioids. In addition, 2 (1%) patients had difficulty managing their postoperative pain and were prescribed opioids within 7 days of surgery. Ultimately, 99% (223 of 226) of patients managed their postoperative pain after discharge without opioids. This represents a significant decrease in opioid use after breast conserving surgery, from 40% in 2016 to 1% after pathway implementation, p < 0.001. CONCLUSIONS: When a multimodal nonopioid pain pathway was implemented, 99% of patients undergoing breast-conserving surgery did not require opioids after discharge.
引用
- Kang R, Read JT, Glaser AC, et al. Eliminating Opioids from Breast Conserving Surgery: Perioperative Pain Management Pathway. J Am Coll Surg. 2020. PMID: 32451057. doi:10.1016/j.jamcollsurg.2020.03.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。